Malignancy after Heart Transplantation: Analysis of 24-Year Experience at a Single Center
- 1 September 2009
- journal article
- Published by Hindawi Limited in Journal of Cardiac Surgery
- Vol. 24 (5), 572-579
- https://doi.org/10.1111/j.1540-8191.2009.00858.x
Abstract
Malignancy is an important complication after heart transplantation. The incidence, spectrum, risk factors, and clinical impact of posttransplant malignancy were investigated in a cohort of patients with long-term follow-up at a single center.Data for 835 patients who underwent heart transplantation between 1979 and 2002 and survived beyond one month were retrospectively evaluated for posttransplant skin cancer, solid organ tumors, and lymphoma.One hundred thirty-nine malignancies developed in 126 patients (15.1%). Skin cancer, solid organ tumors, and lymphoma represented 49%, 27%, and 24% of the malignancies, respectively. Mean patient age at transplantation for patients developing skin cancer, solid organ tumor, and lymphoma were 50 years, 51 years, and 46 years, respectively (p = 0.024). Risk factors for skin cancer were: age greater than 40 at transplantation, number of treated rejection episodes in the first year after transplantation, and smoking history. Variables associated with solid organ malignancy development were age and smoking history. There was no variable related to the development of posttransplant lymphoma. Median survival after diagnosis of skin cancer, solid organ tumor, and lymphoma were 5.0 years, 0.3 years, and 0.7 years, respectively (p < 0.001).Posttransplant malignancies have different risk factors and variable clinical impact. Older age at transplantation, smoking history, and more episodes of treated rejection were related to increased incidence of nonlymphoid malignancy incidence after heart transplantation, whereas no variable was associated with lymphoid malignancy. Skin cancers have a benign course, while solid organ malignancies and lymphomas carry an unfavorable prognosis.Keywords
This publication has 15 references indexed in Scilit:
- Neoplastic disease after heart transplantation: single center experienceEuropean Journal of Cardio-Thoracic Surgery, 2001
- Tumor incidence in heart transplant patients: report of the North Italy Transplant Program RegistryTransplantation Proceedings, 2001
- KAPOSI'S SARCOMA IN TRANSPLANT RECIPIENTSTransplantation, 1997
- REDUCED INCIDENCE OF EPSTEIN-BARR VIRUS-ASSOCIATED POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER USING PREEMPTIVE ANTIVIRAL THERAPY1Transplantation, 1997
- De novo solid malignancies after cardiac transplantationThe Annals of Thoracic Surgery, 1995
- Solid tumors after heart transplantation: Lethality of lung cancerThe Annals of Thoracic Surgery, 1995
- TRANSMISSION OF CNS MALIGNANCY BY ORGAN TRANSPLANTATION1,2Transplantation, 1994
- Incidence of non-hodgkin lymphoma in kidney and heart transplant recipientsThe Lancet, 1993
- Increased Incidence of Lymphoproliferative Disorder after Immunosuppression with the Monoclonal Antibody OKT3 in Cardiac-Transplant RecipientsThe New England Journal of Medicine, 1990
- Association of Cigarette Smoking with Decreased Numbers of Circulating Natural Killer CellsAmerican Review of Respiratory Disease, 1989